terbutaline has been researched along with Diabetes, Gestational in 7 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Diabetes, Gestational: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effects of oxytocin in late pregnancy were also investigated." | 3.75 | Effects of experimentally induced diabetes mellitus on pharmacologically and electrically elicited myometrial contractility. ( Csík, G; Csonka, D; Falkay, G; Minorics, R; Spiegl, G; Zupkó, I, 2009) |
| "The incidence of gestational diabetes is not increased in patients receiving terbutaline via the subcutaneous pump." | 2.67 | Maternal glucose intolerance and the subcutaneous terbutaline pump. ( Cohen, AW; Lindenbaum, C; Ludmir, J; Samuels, P; Teplick, FB, 1992) |
| "To determine whether the incidence of gestational diabetes mellitus (GDM) is increased in patients receiving corticosteroids with or without beta-adrenergic agents for threatened preterm delivery." | 1.30 | Gestational diabetes mellitus in women receiving beta-adrenergics and corticosteroids for threatened preterm delivery. ( Fisher, JE; Lagrandeur, R; Lorenz, RP; Smith, RS, 1997) |
| "Their gestational diabetes screening results were compared to the results in 82 women not receiving beta-mimetic therapy." | 1.29 | Terbutaline tocolysis and glucose intolerance. ( Belluomini, J; Katz, M; Regenstein, AC, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spiegl, G | 1 |
| Zupkó, I | 1 |
| Minorics, R | 1 |
| Csík, G | 1 |
| Csonka, D | 1 |
| Falkay, G | 1 |
| Peterson, A | 1 |
| Peterson, K | 1 |
| Tongen, S | 1 |
| Guzman, M | 1 |
| Corbett, V | 1 |
| Langer, O | 1 |
| Mazze, R | 1 |
| Foley, MR | 1 |
| Landon, MB | 1 |
| Gabbe, SG | 1 |
| O'Dorisio, TM | 1 |
| Waxman, M | 1 |
| Leard, R | 1 |
| Iams, JD | 1 |
| Regenstein, AC | 1 |
| Belluomini, J | 1 |
| Katz, M | 1 |
| Fisher, JE | 1 |
| Smith, RS | 1 |
| Lagrandeur, R | 1 |
| Lorenz, RP | 1 |
| Chan, AY | 1 |
| Silverman, RK | 1 |
| Smith, FC | 1 |
| Geifman-Holtzman, O | 1 |
| Lindenbaum, C | 1 |
| Ludmir, J | 1 |
| Teplick, FB | 1 |
| Cohen, AW | 1 |
| Samuels, P | 1 |
1 trial available for terbutaline and Diabetes, Gestational
| Article | Year |
|---|---|
Maternal glucose intolerance and the subcutaneous terbutaline pump.
Topics: Administration, Oral; Diabetes, Gestational; Female; Glucose; Glucose Tolerance Test; Homeostasis; H | 1992 |
6 other studies available for terbutaline and Diabetes, Gestational
| Article | Year |
|---|---|
Effects of experimentally induced diabetes mellitus on pharmacologically and electrically elicited myometrial contractility.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Animals; Diabetes Mellitu | 2009 |
Glucose intolerance as a consequence of oral terbutaline treatment for preterm labor.
Topics: Adult; Blood Glucose; Delivery, Obstetric; Diabetes, Gestational; Female; Glucose Tolerance Test; Hu | 1993 |
Effect of prolonged oral terbutaline therapy on glucose tolerance in pregnancy.
Topics: Administration, Oral; Adult; Blood Glucose; Body Mass Index; Diabetes, Gestational; Female; Glucagon | 1993 |
Terbutaline tocolysis and glucose intolerance.
Topics: Administration, Oral; Adult; Diabetes, Gestational; Female; Glucose Tolerance Test; Humans; Incidenc | 1993 |
Gestational diabetes mellitus in women receiving beta-adrenergics and corticosteroids for threatened preterm delivery.
Topics: Adrenergic beta-Agonists; Anti-Inflammatory Agents; Betamethasone; Case-Control Studies; Diabetes, G | 1997 |
In utero treatment of fetal complete heart block with terbutaline. A case report.
Topics: Administration, Oral; Adult; Cardiac Pacing, Artificial; Cesarean Section; Diabetes, Gestational; El | 1999 |